Related Experiment Videos
Nitric oxide and cardiac failure
Abstract:
Cardiac myocytes express two types of nitric oxide (NO) synthase, eNOS and iNOS. eNOS activity is regulated by the contractile state of the heart, while iNOS expression is induced by cytokines. Nitric oxide induced by cytokines causes negative inotropic and lethal effects on cardiac myocytes. Expression of iNOS in the myocardium is increased in patients with dilated cardiomyopathy with clinical evidence of heart failure. Several neurohumoral factors activated in chronic heart failure augment cardiac iNOS expression and could cause cardiac dysfunction and cell damage.
Insights
Cardiac myocytes produce nitric oxide (NO) via eNOS and iNOS. Increased inducible NO synthase (iNOS) in heart failure contributes to cardiac dysfunction and cell damage.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Biomedical Science
Background:
- Cardiac myocytes express two nitric oxide (NO) synthase isoforms: endothelial NO synthase (eNOS) and inducible NO synthase (iNOS).
- eNOS activity is modulated by cardiac contractility, whereas iNOS expression is induced by inflammatory cytokines.
- Cytokine-induced NO production negatively impacts cardiac myocyte function and viability.
Purpose of the Study:
- To investigate the role and implications of iNOS expression in cardiac myocytes, particularly in the context of heart failure.
- To understand the relationship between neurohumoral factors, iNOS expression, and cardiac dysfunction in chronic heart failure.
Main Methods:
- Analysis of iNOS expression in cardiac myocytes.
- Investigation of iNOS regulation by cytokines and neurohumoral factors.
- Assessment of the functional and viability effects of NO produced by iNOS.
Main Results:
- iNOS expression is elevated in the myocardium of patients with dilated cardiomyopathy and heart failure.
- Activated neurohumoral factors in chronic heart failure exacerbate cardiac iNOS expression.
- Elevated iNOS activity contributes to cardiac dysfunction and myocyte damage.
Conclusions:
- Increased cardiac iNOS expression is a significant factor in the pathophysiology of heart failure.
- Targeting iNOS may offer a therapeutic strategy for managing heart failure and preventing cardiac damage.